For citations:
Suplotova L.A., Plotnikov N.V., Romanova N.V., Bel’chikova L.N., Khieva E.V., Shestakova M.V. Data on the first experience of insulin degludec (Tresiba®) treatment for type 2 diabetes in daily clinical practice. Diabetes mellitus. 2015;18(4):92-98. (In Russ.) https://doi.org/10.14341/DM7695
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
